chr2-166199711-G-T

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong

The NM_001365536.1(SCN9A):​c.4928C>A​(p.Ala1643Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1643T) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 31)

Consequence

SCN9A
NM_001365536.1 missense

Scores

16
2
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 9.86
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.986
PP5
Variant 2-166199711-G-T is Pathogenic according to our data. Variant chr2-166199711-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 245903.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-166199711-G-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SCN9ANM_001365536.1 linkuse as main transcriptc.4928C>A p.Ala1643Glu missense_variant 27/27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkuse as main transcriptc.4928C>A p.Ala1643Glu missense_variant 27/27 NM_001365536.1 ENSP00000495601.1 Q15858-1
SCN9AENST00000303354.11 linkuse as main transcriptc.4928C>A p.Ala1643Glu missense_variant 27/275 ENSP00000304748.7 Q15858-1
SCN9AENST00000409672.5 linkuse as main transcriptc.4895C>A p.Ala1632Glu missense_variant 27/275 ENSP00000386306.1 Q15858-3
SCN9AENST00000645907.1 linkuse as main transcriptc.4895C>A p.Ala1632Glu missense_variant 27/27 ENSP00000495983.1 Q15858-4

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Paroxysmal extreme pain disorder Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingCenter of Genomic medicine, Geneva, University Hospital of GenevaFeb 13, 2017- -
Pathogenic, no assertion criteria providedresearchDepartment of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental SciencesNov 16, 2021- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGeneDxAug 25, 2015The A1632E missense variant in the SCN9A gene has been reported previously as a de novo variant in a patient with characteristics of both inherited erythromelalgia (IEM) and paroxysmal extreme pain disorder (PEPD) (Estacion et al., 2008). Functional analysis shows that A1632E alters channel function and results in neuronal hyperexciability (Estacion et al., 2008). The A1632E variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. It is a non-conservative amino acid substitution that occurs at a highly conserved position in between the S4 and S5 transmembrane segments of the forth homologous domain. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.57
D
BayesDel_noAF
Pathogenic
0.58
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.95
.;D;.;.;D;.
Eigen
Pathogenic
0.98
Eigen_PC
Pathogenic
0.87
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D;.;D;D;D;D
M_CAP
Pathogenic
0.72
D
MetaRNN
Pathogenic
0.99
D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.9
.;H;.;.;H;H
PrimateAI
Pathogenic
0.90
D
PROVEAN
Pathogenic
-4.5
D;.;.;.;.;D
REVEL
Pathogenic
0.96
Sift
Pathogenic
0.0
D;.;.;.;.;D
Sift4G
Pathogenic
0.0
D;D;.;.;.;D
Vest4
0.93
MutPred
0.91
Gain of relative solvent accessibility (P = 0.1259);.;Gain of relative solvent accessibility (P = 0.1259);.;.;.;
MVP
0.96
MPC
0.60
ClinPred
1.0
D
GERP RS
5.7
Varity_R
0.94
gMVP
0.99

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs879253994; hg19: chr2-167056221; API